Citation:Overman, MJ Kopetz, S McDermott, RS Leach, J Lonardi, S Lenz, H-J Morse, MA Desai, J Hill, A Axelson, M.D. Moss, R.A. Lin, C-S Goldberg, M Andre, T 2016

Citation

Overman, MJ Kopetz, S McDermott, RS Leach, J Lonardi, S Lenz, H-J Morse, MA Desai, J Hill, A Axelson, M.D. Moss, R.A. Lin, C-S Goldberg, M Andre, T. Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): CheckMate-142 interim results. J Clin Oncol 2016;34, abstract 3501 Available from: http://meetinglibrary.asco.org/content/166455-176.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Molecular pathology and biomarkers – implications for systemic therapy